ARYA Sciences Acquisition Corp II
Completed 2020-10-27- CIK 1805387
- ARYB
- Now CERE
- IPO 2020-06-08
- $150M trust
- 448 filings
Successfully merged with Cerevel Therapeutics, Inc. • Now trading as CERE
- IPO Size
- $150M
- raised at the IPO
- Trust
- $150M
- as of 2020-09-30
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2020
- year it listed
Filings, by quarter
448 filings over 19 quarters; violet bars carry a milestone
- 20 Q1: 1 filing
- 20 Q2: 24 filings
- 20 Q3: 12 filings
- 20 Q4: 62 filings
- 21 Q1: 23 filings
- 21 Q2: 32 filings
- 21 Q3: 21 filings
- 21 Q4: 13 filings
- 22 Q1: 18 filings
- 22 Q2: 23 filings
- 22 Q3: 19 filings
- 22 Q4: 10 filings
- 23 Q1: 17 filings
- 23 Q2: 38 filings
- 23 Q3: 9 filings
- 23 Q4: 44 filings
- 24 Q1: 26 filings
- 24 Q2: 18 filings
- 24 Q3: 38 filings
- S-1 filed 20 Q1
- IPO 20 Q2
- Definitive agreement 20 Q3
- Completed 20 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
ARYA Sciences Acquisition Corp II is a blank-check company seeking to complete an initial business combination. It intends to target North American or European companies in the life sciences and medical technology sectors, focusing on healthcare and healthcare-related industries.
Investment Focus
Healthcare
Geographic Focus
North America, Europe
Key Information
As the filings state it
- IPO Date
- 2020-06-08
- Total Redemptions
- $2.5M
- PIPE
- $320M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2020-10-27
- Merger Target
- Cerevel Therapeutics, Inc.
- SPAC Ticker
- ARYB
- Merged Ticker
- CERE
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team is led by Perceptive Advisors founders and senior executives Joseph Edelman, Adam Stone, Michael Altman and Konstantin Poukalov, with extensive healthcare and life-sciences investment experience. Director nominees contribute experience in biotechnology, pharmaceutical company operations, corporate development and healthcare entrepreneurship.